CN103446479B - 一种治疗过食油炸食物型腋下急性化脓性淋巴结炎的中药 - Google Patents
一种治疗过食油炸食物型腋下急性化脓性淋巴结炎的中药 Download PDFInfo
- Publication number
- CN103446479B CN103446479B CN201310367496.1A CN201310367496A CN103446479B CN 103446479 B CN103446479 B CN 103446479B CN 201310367496 A CN201310367496 A CN 201310367496A CN 103446479 B CN103446479 B CN 103446479B
- Authority
- CN
- China
- Prior art keywords
- grams
- herba
- radix
- heat
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 34
- 230000001154 acute effect Effects 0.000 title claims abstract description 22
- 235000013305 food Nutrition 0.000 title abstract description 6
- NOQGZXFMHARMLW-UHFFFAOYSA-N Daminozide Chemical compound CN(C)NC(=O)CCC(O)=O NOQGZXFMHARMLW-UHFFFAOYSA-N 0.000 title abstract 4
- 206010020710 Hyperphagia Diseases 0.000 title abstract 4
- 201000003265 lymphadenitis Diseases 0.000 title abstract 4
- 235000020830 overeating Nutrition 0.000 title abstract 4
- 238000011282 treatment Methods 0.000 claims abstract description 16
- 241001116755 Selliguea Species 0.000 claims abstract description 7
- 210000001099 axilla Anatomy 0.000 claims description 20
- 201000009052 suppurative lymphadenitis Diseases 0.000 claims description 18
- 241000628997 Flos Species 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 7
- 241000563984 Ampelopsis Species 0.000 claims description 6
- 241000746375 Andrographis Species 0.000 claims description 6
- 241000959626 Calvatia Species 0.000 claims description 6
- 235000009388 Parthenocissus quinquefolia Nutrition 0.000 claims description 6
- 241001250596 Pleione Species 0.000 claims description 6
- 241000218206 Ranunculus Species 0.000 claims description 6
- 239000010231 banlangen Substances 0.000 claims description 6
- 210000000582 semen Anatomy 0.000 claims description 6
- 229940126678 chinese medicines Drugs 0.000 claims description 3
- 239000003643 water by type Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 10
- 238000000034 method Methods 0.000 abstract description 6
- 231100000331 toxic Toxicity 0.000 abstract description 5
- 230000002588 toxic effect Effects 0.000 abstract description 5
- 238000002360 preparation method Methods 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 3
- 239000003242 anti bacterial agent Substances 0.000 abstract description 2
- 229940088710 antibiotic agent Drugs 0.000 abstract description 2
- 150000003456 sulfonamides Chemical class 0.000 abstract description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 2
- 244000118350 Andrographis paniculata Species 0.000 abstract 1
- 241000596154 Belamcanda Species 0.000 abstract 1
- 240000000724 Berberis vulgaris Species 0.000 abstract 1
- 235000018185 Betula X alpestris Nutrition 0.000 abstract 1
- 235000018212 Betula X uliginosa Nutrition 0.000 abstract 1
- 241001195282 Bidens biternata Species 0.000 abstract 1
- 241000233838 Commelina Species 0.000 abstract 1
- 241000037740 Coptis chinensis Species 0.000 abstract 1
- 244000247747 Coptis groenlandica Species 0.000 abstract 1
- 235000002991 Coptis groenlandica Nutrition 0.000 abstract 1
- 241000221079 Euphorbia <genus> Species 0.000 abstract 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 1
- 241000466334 Hemsleya macrosperma Species 0.000 abstract 1
- 241000209035 Ilex Species 0.000 abstract 1
- 235000003332 Ilex aquifolium Nutrition 0.000 abstract 1
- 235000002296 Ilex sandwicensis Nutrition 0.000 abstract 1
- 235000002294 Ilex volkensiana Nutrition 0.000 abstract 1
- 241000334154 Isatis tinctoria Species 0.000 abstract 1
- 241000745390 Lophatherum Species 0.000 abstract 1
- 240000007019 Oxalis corniculata Species 0.000 abstract 1
- 235000016499 Oxalis corniculata Nutrition 0.000 abstract 1
- 244000233952 Polygonum bistorta Species 0.000 abstract 1
- 235000014258 Polygonum bistorta Nutrition 0.000 abstract 1
- 241001448530 Rohdea japonica Species 0.000 abstract 1
- 241001411234 Sagina subulata Species 0.000 abstract 1
- 241001647091 Saxifraga granulata Species 0.000 abstract 1
- 241000017433 Schefflera heptaphylla Species 0.000 abstract 1
- 244000072882 Sedum telephium Species 0.000 abstract 1
- 235000019098 Sedum telephium Nutrition 0.000 abstract 1
- 244000269722 Thea sinensis Species 0.000 abstract 1
- 241000208241 Tropaeolum Species 0.000 abstract 1
- 244000029687 Wikstroemia indica Species 0.000 abstract 1
- 230000007547 defect Effects 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- IWBJJCOKGLUQIZ-HQKKAZOISA-N hyperforin Chemical compound OC1=C(CC=C(C)C)C(=O)[C@@]2(CC=C(C)C)C[C@H](CC=C(C)C)[C@](CCC=C(C)C)(C)[C@]1(C(=O)C(C)C)C2=O IWBJJCOKGLUQIZ-HQKKAZOISA-N 0.000 abstract 1
- QOVWXXKVLJOKNW-UHFFFAOYSA-N hyperforin Natural products CC(C)C(=O)C12CC(CC=C(C)C)(CC(CC=C(C)C)C1CCC=C(C)C)C(=C(CC=C(C)C)C2=O)O QOVWXXKVLJOKNW-UHFFFAOYSA-N 0.000 abstract 1
- 229910052742 iron Inorganic materials 0.000 abstract 1
- 229940010454 licorice Drugs 0.000 abstract 1
- 239000002893 slag Substances 0.000 abstract 1
- 238000002791 soaking Methods 0.000 abstract 1
- 229940124530 sulfonamide Drugs 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 231100000614 poison Toxicity 0.000 description 45
- 239000003440 toxic substance Substances 0.000 description 40
- 210000004185 liver Anatomy 0.000 description 33
- 210000004072 lung Anatomy 0.000 description 31
- 239000008280 blood Substances 0.000 description 29
- 210000004369 blood Anatomy 0.000 description 29
- 208000002193 Pain Diseases 0.000 description 22
- 210000002216 heart Anatomy 0.000 description 20
- 230000023597 hemostasis Effects 0.000 description 20
- 230000001737 promoting effect Effects 0.000 description 20
- 208000004880 Polyuria Diseases 0.000 description 18
- 230000035619 diuresis Effects 0.000 description 18
- 210000002784 stomach Anatomy 0.000 description 18
- 235000009508 confectionery Nutrition 0.000 description 17
- 238000001816 cooling Methods 0.000 description 17
- 210000002429 large intestine Anatomy 0.000 description 17
- 230000008961 swelling Effects 0.000 description 14
- 210000000952 spleen Anatomy 0.000 description 13
- 229940079593 drug Drugs 0.000 description 12
- 206010020751 Hypersensitivity Diseases 0.000 description 8
- 206010062717 Increased upper airway secretion Diseases 0.000 description 8
- 230000007815 allergy Effects 0.000 description 8
- 210000003734 kidney Anatomy 0.000 description 8
- 208000026435 phlegm Diseases 0.000 description 8
- 230000007096 poisonous effect Effects 0.000 description 8
- 208000026935 allergic disease Diseases 0.000 description 7
- 238000001035 drying Methods 0.000 description 6
- 230000001939 inductive effect Effects 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 5
- 229930182555 Penicillin Natural products 0.000 description 5
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 5
- 230000000968 intestinal effect Effects 0.000 description 5
- 238000010255 intramuscular injection Methods 0.000 description 5
- 239000007927 intramuscular injection Substances 0.000 description 5
- 231100000252 nontoxic Toxicity 0.000 description 5
- 230000003000 nontoxic effect Effects 0.000 description 5
- 229940049954 penicillin Drugs 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 206010037660 Pyrexia Diseases 0.000 description 4
- 230000004438 eyesight Effects 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 231100000167 toxic agent Toxicity 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 206010068319 Oropharyngeal pain Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 208000003455 anaphylaxis Diseases 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000007803 itching Effects 0.000 description 3
- 239000010985 leather Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- UUTKICFRNVKFRG-WDSKDSINSA-N (4R)-3-[oxo-[(2S)-5-oxo-2-pyrrolidinyl]methyl]-4-thiazolidinecarboxylic acid Chemical compound OC(=O)[C@@H]1CSCN1C(=O)[C@H]1NC(=O)CC1 UUTKICFRNVKFRG-WDSKDSINSA-N 0.000 description 2
- 206010002199 Anaphylactic shock Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000015817 Infant Nutrition disease Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 102000003929 Transaminases Human genes 0.000 description 2
- 108090000340 Transaminases Proteins 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 210000003800 pharynx Anatomy 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000002048 spasmolytic effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 210000001364 upper extremity Anatomy 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 201000010000 Agranulocytosis Diseases 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- WZPBZJONDBGPKJ-UHFFFAOYSA-N Antibiotic SQ 26917 Natural products O=C1N(S(O)(=O)=O)C(C)C1NC(=O)C(=NOC(C)(C)C(O)=O)C1=CSC(N)=N1 WZPBZJONDBGPKJ-UHFFFAOYSA-N 0.000 description 1
- 241000244186 Ascaris Species 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 206010009657 Clostridium difficile colitis Diseases 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011509 Crystalluria Diseases 0.000 description 1
- 206010011894 Deafness permanent Diseases 0.000 description 1
- 208000006313 Delayed Hypersensitivity Diseases 0.000 description 1
- 206010013886 Dysaesthesia Diseases 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 206010053155 Epigastric discomfort Diseases 0.000 description 1
- 206010018687 Granulocytopenia Diseases 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010033661 Pancytopenia Diseases 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 208000003100 Pseudomembranous Enterocolitis Diseases 0.000 description 1
- 206010037128 Pseudomembranous colitis Diseases 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 229940075522 antidotes Drugs 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- WZPBZJONDBGPKJ-VEHQQRBSSA-N aztreonam Chemical compound O=C1N(S([O-])(=O)=O)[C@@H](C)[C@@H]1NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC([NH3+])=N1 WZPBZJONDBGPKJ-VEHQQRBSSA-N 0.000 description 1
- 229960003644 aztreonam Drugs 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 229960003669 carbenicillin Drugs 0.000 description 1
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 1
- 229960004682 cefoperazone Drugs 0.000 description 1
- GCFBRXLSHGKWDP-XCGNWRKASA-N cefoperazone Chemical compound O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC(O)=CC=1)C(=O)N[C@@H]1C(=O)N2C(C(O)=O)=C(CSC=3N(N=NN=3)C)CS[C@@H]21 GCFBRXLSHGKWDP-XCGNWRKASA-N 0.000 description 1
- 229960004261 cefotaxime Drugs 0.000 description 1
- GPRBEKHLDVQUJE-VINNURBNSA-N cefotaxime Chemical compound N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C(O)=O)=O)C(=O)/C(=N/OC)C1=CSC(N)=N1 GPRBEKHLDVQUJE-VINNURBNSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000860 cochlear nerve Anatomy 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 208000001297 phlebitis Diseases 0.000 description 1
- 229960002292 piperacillin Drugs 0.000 description 1
- IVBHGBMCVLDMKU-GXNBUGAJSA-N piperacillin Chemical compound O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC=CC=1)C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 IVBHGBMCVLDMKU-GXNBUGAJSA-N 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- ZRHANBBTXQZFSP-UHFFFAOYSA-M potassium;4-amino-3,5,6-trichloropyridine-2-carboxylate Chemical compound [K+].NC1=C(Cl)C(Cl)=NC(C([O-])=O)=C1Cl ZRHANBBTXQZFSP-UHFFFAOYSA-M 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 229960005404 sulfamethoxazole Drugs 0.000 description 1
- JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 201000005060 thrombophlebitis Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
年龄(岁) | 23~30 | 31~40 | 41~50 | 51~62 |
例数 | 12 | 229 | 137 | 11 |
百分比 | 3.1% | 58.9% | 35.2% | 2.8% |
疗效 | 治愈 | 好转 | 无效 |
例数 | 386 | 3 | 无 |
百分比 | 99.2% | 0.8% | 无 |
治疗天数 | 3~5 | 6~9 | 10~14 | 15~27 |
例数 | 13 | 249 | 111 | 16 |
百分比 | 3.4% | 64% | 28.5% | 4.1% |
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310367496.1A CN103446479B (zh) | 2013-08-22 | 2013-08-22 | 一种治疗过食油炸食物型腋下急性化脓性淋巴结炎的中药 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310367496.1A CN103446479B (zh) | 2013-08-22 | 2013-08-22 | 一种治疗过食油炸食物型腋下急性化脓性淋巴结炎的中药 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103446479A CN103446479A (zh) | 2013-12-18 |
CN103446479B true CN103446479B (zh) | 2015-06-17 |
Family
ID=49729591
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310367496.1A Expired - Fee Related CN103446479B (zh) | 2013-08-22 | 2013-08-22 | 一种治疗过食油炸食物型腋下急性化脓性淋巴结炎的中药 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103446479B (zh) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103230544A (zh) * | 2013-04-30 | 2013-08-07 | 付玲玲 | 一种治疗过食川椒型脓性指头炎的中药洗剂制备方法 |
CN103251836A (zh) * | 2013-05-25 | 2013-08-21 | 于虎 | 一种治疗嗜食生葱型贲门炎的中药制备方法 |
-
2013
- 2013-08-22 CN CN201310367496.1A patent/CN103446479B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN103446479A (zh) | 2013-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102743633A (zh) | 一种治疗腐肉型蜂窝组织炎的中药洗剂制备方法 | |
CN103463508A (zh) | 一种治疗过食烤鱼型前庭大腺炎的中药洗剂制备方法 | |
CN103463523B (zh) | 一种治疗热毒炽盛型腋下急性化脓性淋巴结炎中药 | |
CN103463447A (zh) | 一种治疗目赤型前庭大腺炎的中药洗剂制备方法 | |
CN103463370B (zh) | 一种治疗嗜食牛肚型腋下急性化脓性淋巴结炎的中药 | |
CN103463337B (zh) | 一种治疗经络阻滞型腋下急性化脓性淋巴结炎的中药 | |
CN103446479B (zh) | 一种治疗过食油炸食物型腋下急性化脓性淋巴结炎的中药 | |
CN103230543A (zh) | 一种治疗嗜食芥茉型脓性指头炎的中药洗剂制备方法 | |
CN103432405B (zh) | 一种治疗嗜食肥肉型腋下急性化脓性淋巴结炎的中药 | |
CN103432454A (zh) | 一种治疗酗酒型腋下急性化脓性淋巴结炎的中药制备方法 | |
CN103446480B (zh) | 一种治疗过食熏鸡型腋下急性化脓性淋巴结炎的中药 | |
CN103463434A (zh) | 一种治疗发热型腋下急性化脓性淋巴结炎的中药制备方法 | |
CN103463336B (zh) | 一种治疗过食川椒型腋下急性化脓性淋巴结炎的中药 | |
CN103432451B (zh) | 一种治疗过食猪大肠型腋下急性化脓性淋巴结炎的中药 | |
CN103463433A (zh) | 一种治疗口渴型腋下急性化脓性淋巴结炎的中药制备方法 | |
CN103446533B (zh) | 一种治疗肝郁化火型腋下急性化脓性淋巴结炎的中药 | |
CN103432408B (zh) | 一种治疗痰浊壅塞型腋下急性化脓性淋巴结炎的中药 | |
CN103432406A (zh) | 一种治疗肿块型腋下急性化脓性淋巴结炎的中药制备方法 | |
CN103432407B (zh) | 一种治疗过食猪肝型腋下急性化脓性淋巴结炎的中药 | |
CN103432409B (zh) | 一种治疗嗜食烤肉型腋下急性化脓性淋巴结炎的中药 | |
CN103463475A (zh) | 一种治疗血热型根尖周炎的中药制备方法 | |
CN103479925A (zh) | 一种治疗痰火内扰型前庭大腺炎的中药洗剂制备方法 | |
CN103432483A (zh) | 一种治疗瘀血型腋下急性化脓性淋巴结炎的中药制备方法 | |
CN103463319A (zh) | 一种治疗嗜食鲜姜型前庭大腺炎的中药洗剂制备方法 | |
CN103463435A (zh) | 一种治疗过食芥茉型腋下急性化脓性淋巴结炎的中药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: ZHENG TIANYING Free format text: FORMER OWNER: DONG JIAMEI Effective date: 20150515 Owner name: WANG QINGLING XU QINGQUAN JI LIPING Effective date: 20150515 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Zheng Tiancheng Inventor after: Wang Qingling Inventor after: Xu Qingquan Inventor after: Ji Liping Inventor before: Dong Jiamei |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: DONG JIAMEI TO: ZHENG TIANYING WANG QINGLING XU QINGQUAN JI LIPING |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20150515 Address after: 250012 Center for chemotherapy, Qilu Hospital,, 107 west road, Shandong, Ji'nan, China Applicant after: Zheng Tiancheng Applicant after: Wang Qingling Applicant after: Xu Qingquan Applicant after: Ji Liping Address before: 250200 Zhangqiu chronic disease control station, 6 West Ring Road, Zhangqiu, Shandong, Ji'nan Applicant before: Dong Jiamei |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160614 Address after: 250012 No. 107, Wenhua West Road, Shandong, Ji'nan Patentee after: Shandong Qilu Hospital Address before: 250012 Center for chemotherapy, Qilu Hospital,, 107 west road, Shandong, Ji'nan, China Patentee before: Zheng Tiancheng Patentee before: Wang Qingling Patentee before: Xu Qingquan Patentee before: Ji Liping |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150617 Termination date: 20150822 |
|
EXPY | Termination of patent right or utility model |